Carisma Therapeutics Inc. (CARM) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.00x

Carisma Therapeutics Inc. (CARM) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.91 Million. Explore reinvestment intensity of Carisma Therapeutics Inc. to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$1.91 Million
USD

Capital Expenditures

$0.00
USD

Carisma Therapeutics Inc. Cash Flow Reinvestment Rate (2016–2016)

Historical reinvestment intensity for Carisma Therapeutics Inc. across 1 annual periods. Also explore CARM total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Carisma Therapeutics Inc. (2016–2016)

Year-by-year capital reinvestment analysis for Carisma Therapeutics Inc.. For live market cap and broader valuation context, see CARM market cap overview.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2016 0.00x $0.00 $2.62 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow